Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma
Noémie S. Minczeles, Eelke M. Bos, Reinoud C. de Leeuw, Johan M. Kros, Mark Konijnenberg, Jacoline E. C. Bromberg, Wouter W. de Herder, Clemens M.F. Dirven, Johannes Hofland, Tessa Brabander
Topics & Concepts
Radionuclide therapyMedicineProgressive diseaseRefractory (planetary science)MeningiomaNuclear medicineRadiation therapyRetrospective cohort studySurgeryInternal medicineUrologyChemotherapyPhysicsAstrobiologyMeningioma and schwannoma managementRadiopharmaceutical Chemistry and ApplicationsTrigeminal Neuralgia and Treatments